First Experience Using Contrast‐enhanced Ultrasound to Evaluate Vascularisation of Acellular Dermal Matrices after Implant‐Based Breast Reconstruction. Issue 5 (7th July 2014)

• Record Type: Journal Article
• Authors: Parvizi, Daryousch; Haas, Franz; Peintinger, Florentia; Hubmer, Martin; Rappl, Thomas; Koch, Horst; Schintler, Michael; Spendel, Stephan; Kamolz, Lars‐Peter; Wurzer, Paul; Tuca, Alexandru; Fuchsjaeger, Michael; Weinke, Roland
• Is Part Of: Breast journal. Volume 20:Issue 5(2014:Sep./Oct.)
• Page Start: 461
• Page End: 467
• Publication Date: 2014-07-07
• Subjects: Breast -- Diseases -- Periodicals; Breast -- Cancer -- Periodicals; 618.19
• DOI: 10.1111/tbj.12301
• Languages: English
• ISSNs: 1075-122X

Abstract

<abstract abstract-type="main" id="tbj12301-abs-0001"> <title>Abstract</title> <p>Acellular dermal matrices (ADM) have been used frequently in therapeutic and prophylactic breast procedures. To date there have been no reports on vascularisation of ADMs and formation of tissue around them as seen with modern non‐invasive imaging techniques such as contrast‐enhanced ultrasound (CEUS). In this case series, we used CEUS to investigate the features of ADM in relation to vascular ingrowth and scaffold for "new" tissue formation. This is a retrospective evaluation of patients who underwent successful skin‐ and nipple‐sparing mastectomy (SSM, NSM) with immediate IBBR using ADM from May 31, 2010, through December 28, 2012. Over a 24‐month period, 16 patients, with an average age of 44 years (range 27–70 years), were evaluated with CEUS. No contrast agent allergies or side effects were reported for the ultrasound examination. After contrast agent injection (1–18 months postoperatively), homogeneous normal enhancement in the ADM and peripheral region with physiological tissue formation was seen in all patients. In this small study, the most obvious contribution of CEUS is the in vivo evaluation of vascular ingrowth and tissue formation after IBBR with ADM after follow‐up of 1–18 months postoperatively.</p> <p>Level of Evidence III: Retrospective cohort or comparative study; case–control study; or systematic review of these studies.</p> </abstract>